pharmacogenomic love



from Wiktionary, Creative Commons Attribution/Share-Alike License

  • adj. Of or pertaining to pharmacogenomics


Sorry, no etymologies found.


  • The company said it plans to introduce so-called pharmacogenomic clinical services to its PBM clients in the second quarter of 2010.

    Nashville Business News - Local Nashville News | The Nashville Business Journal

  • On Wednesday, the Food and Drug Administration issued guidelines for interpreting "pharmacogenomic" data (see fda. gov).

    Personalized Health

  • Given the extraordinarily high costs of newer cancer drugs, "pharmacogenomic" tests are seen as crucial to avoiding futile, wasteful treatment. - Latest Videos

  • "The AMA is committed to providing education and resources to physicians in this growing and important area of medical science so that they can appropriately use genetically-based technology, such as pharmacogenomic testing."


  • The two-year agreement calls for Medco to deliver reports to the FDA about pharmacogenomic testing, including physician participation in such testing and the usefulness of testing in prescribing medicines.

    Medco Health, FDA to Study Role

  • There are currently about two dozen pharmacogenomic tests on the market, according to Dr. Epstein, referring specifically to tests for a patient's compatibility with certain medications and not the broader category of genetic tests for disease risk factors, or genetic predisposition for disease.

    Medco Health, FDA to Study Role

  • In addition to diagnostic testing services, RGI generates revenue from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry.

  • Transgenomic Pharmacogenomics Services is a CRO for pharmacogenomic, translational research and clinical trials.

  • Some health care organizations already offer pharmacogenomic testing to select patients, such as Gooding, and some test manufacturers are marketing directly to consumers, such as Negro, through the Web. News - Top Stories

  • But before they pay for pharmacogenomic testing, some insurers want more evidence that it leads to better patient care, says Robert Epstein, chief medical officer of News - Top Stories


Log in or sign up to get involved in the conversation. It's quick and easy.